|
1
|
Da Costa VM and Rosenthal D: Effects of
aging on thyroidal function and proliferation. Curr Aging Sci.
1:101–104. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cooper DS: Thyroid disease in the oldest
old: The exception to the rule. JAMA. 292:2651–2654. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jones CM and Boelaert K: The endocrinology
of aging: A mini-review. Gerontology. 61:291–300. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pasqualetti G, Caraccio N, Dell Agnello U
and Monzani F: Cognitive function and the aging process: The
peculiar role of mild thyroid failure. Recent Pat Endocr Metab
Immune Drug Discov. 10:4–10. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rukhman N and Silverberg A: Thyroid cancer
in older men. Aging Male. 14:91–98. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mazzaferri EL and Kloos RT: Current
approaches to primary therapy for papillary and follicular thyroid
cancer. J Clin Endocrinol Metab. 86:1447–1463. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Blackburn BE, Ganz PA, Rowe K, Snyder J,
Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, et al:
Aging-related disease risks among young thyroid cancer survivors.
Cancer Epidemiol Biomarkers Prev. 26:1695–1704. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
De Lellis RA, Lloyd RV, Heitz PU and Eng
C: World Health Organization classification of tumours. Pathology
and genetics of tumours of endocrine organs. IARC Press; Lyon,
France: 2004
|
|
9
|
Pérez RF, Tejedor JR, Bayón GF, Fernández
AF and Fraga MF: Distinct chromatin signatures of DNA
hypomethylation in aging and cancer. Aging Cell. 17:e127442018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Krook KA, Fedewa SA and Chen AY:
Prognostic indicators in well-differentiated thyroid carcinoma when
controlling for stage and treatment. Laryngoscope. 125:1021–1027.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ganly I, Nixon IJ, Wang LY, Palmer FL,
Migliacci JC, Aniss A, Sywak M, Eskander AE, Freeman JL, Campbell
MJ, et al: Survival from differentiated thyroid cancer: What has
age got to do with it? Thyroid. 25:1106–1114. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Handkiewicz-Junak D, Swierniak M, Rusinek
D, Oczko-Wojciechowska M, Dom G, Maenhaut C, Unger K, Detours V,
Bogdanova T, Thomas G, et al: Gene signature of the post-Chernobyl
papillary thyroid cancer. Eur J Nucl Med Mol Imaging. 43:1267–1277.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rusinek D, Swierniak M, Chmielik E, Kowal
M, Kowalska M, Cyplinska R, Czarniecka A, Piglowski W, Korfanty J,
Chekan M, et al: BRAFV600E-associated gene expression profile:
Early changes in the transcriptome, based on a transgenic mouse
model of papillary thyroid carcinoma. PLoS One. 10:e01436882015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tarabichi M, Saiselet M, Trésallet C,
Hoang C, Larsimont D, Andry G, Maenhaut C and Detours V: Revisiting
the transcriptional analysis of primary tumours and associated
nodal metastases with enhanced biological and statistical controls:
application to thyroid cancer. Br J Cancer. 112:1665–1674. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
von Roemeling CA, Marlow LA, Pinkerton AB,
Crist A, Miller J, Tun HW, Smallridge RC and Copland JA: Aberrant
lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl
CoA desaturase 1 as a novel therapeutic target. J Clin Endocrinol
Metab. 100:E697–E709. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Versteyhe S, Driessens N, Ghaddhab C,
Tarabichi M, Hoste C, Dumont JE, Miot F, Corvilain B and Detours V:
Comparative analysis of the thyrocytes and T cells: responses to
H2O2 and radiation reveals an
H2O2-induced antioxidant transcriptional
program in thyrocytes. J Clin Endocrinol Metab. 98:E1645–E1654.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pita JM, Banito A, Cavaco BM and Leite V:
Gene expression profiling associated with the progression to poorly
differentiated thyroid carcinomas. Br J Cancer. 101:1782–1791.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dom G, Tarabichi M, Unger K, Thomas G,
Oczko-Wojciechowska M, Bogdanova T, Jarzab B, Dumont JE, Detours V
and Maenhaut C: A gene expression signature distinguishes normal
tissues of sporadic and radiation-induced papillary thyroid
carcinomas. Br J Cancer. 107:994–1000. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tomás G, Tarabichi M, Gacquer D, Hébrant
A, Dom G, Dumont JE, Keutgen X, Fahey TJ III, Maenhaut C and
Detours V: A general method to derive robust organ-specific gene
expression-based differentiation indices: application to thyroid
cancer diagnostic. Oncogene. 31:4490–4498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Giordano TJ, Au AY, Kuick R, Thomas DG,
Rhodes DR, Wilhelm KG Jr, Vinco M, Misek DE, Sanders D, Zhu Z, et
al: Delineation, functional validation, and bioinformatic
evaluation of gene expression in thyroid follicular carcinomas with
the PAX8-PPARG translocation. Clin Cancer Res. 12:1983–1993. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Giordano TJ, Kuick R, Thomas DG, Misek DE,
Vinco M, Sanders D, Zhu Z, Ciampi R, Roh M, Shedden K, et al:
Molecular classification of papillary thyroid carcinoma: distinct
BRAF, RAS, and RET/PTC mutation-specific gene expression profiles
discovered by DNA microarray analysis. Oncogene. 24:6646–6656.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu K, Ganesan K, Tan LK, Laban M, Wu J,
Zhao XD, Li H, Leung CH, Zhu Y, Wei CL, et al: A precisely
regulated gene expression cassette potently modulates metastasis
and survival in multiple solid cancers. PLoS Genet. 4:e10001292008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fontaine JF, Mirebeau-Prunier D, Franc B,
Triau S, Rodien P, Houlgatte R, Malthièry Y and Savagner F:
Microarray analysis refines classification of non-medullary thyroid
tumours of uncertain malignancy. Oncogene. 27:2228–2236. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Salvatore G, Nappi TC, Salerno P, Jiang Y,
Garbi C, Ugolini C, Miccoli P, Basolo F, Castellone MD, Cirafici
AM, et al: A cell proliferation and chromosomal instability
signature in anaplastic thyroid carcinoma. Cancer Res.
67:10148–10158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vasko V, Espinosa AV, Scouten W, He H,
Auer H, Liyanarachchi S, Larin A, Savchenko V, Francis GL, de la
Chapelle A, et al: Gene expression and functional evidence of
epithelial-to-mesenchymal transition in papillary thyroid carcinoma
invasion. Proc Natl Acad Sci USA. 104:2803–2808. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He H, Jazdzewski K, Li W, Liyanarachchi S,
Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, et al:
The role of microRNA genes in papillary thyroid carcinoma. Proc
Natl Acad Sci USA. 102:19075–19080. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He CH, Lee CG, Dela Cruz CS, Lee CM, Zhou
Y, Ahangari F, Ma B, Herzog EL, Rosenberg SA, Li Y, et al:
Chitinase 3-like 1 regulates cellular and tissue responses via
IL-13 receptor α2. Cell Rep. 4:830–841. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pisarev MA, Thomasz L and Juvenal GJ: Role
of transforming growth factor beta in the regulation of thyroid
function and growth. Thyroid. 19:881–892. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhong J, Liu C, Zhang QH, Chen L, Shen YY,
Chen YJ, Zeng X, Zu XY and Cao RX: TGF-β1 induces HMGA1 expression:
The role of HMGA1 in thyroid cancer proliferation and invasion. Int
J Oncol. 50:1567–1578. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tajrishi MM, Sato S, Shin J, Zheng TS,
Burkly LC and Kumar A: The TWEAK-Fn14 dyad is involved in
age-associated pathological changes in skeletal muscle. Biochem
Biophys Res Commun. 446:1219–1224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Van Kirk CA, VanGuilder HD, Young M,
Farley JA, Sonntag WE and Freeman WM: Age-related alterations in
retinal neurovascular and inflammatory transcripts. Mol Vis.
17:1261–1274. 2011.PubMed/NCBI
|
|
32
|
Hénaut L, Sanz AB, Martin-Sanchez D,
Carrasco S, Villa-Bellosta R, Aldamiz-Echevarria G, Massy ZA,
Sanchez-Nino MD and Ortiz A: TWEAK favors phosphate-induced
calcification of vascular smooth muscle cells through canonical and
non-canonical activation of NFκB. Cell Death Dis. 7:e23052016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tong X, Wang D, Liu S, Ma Y, Li Z, Tian P
and Fan H: The YKL-40 protein is a potential biomarker for COPD: A
meta-analysis and systematic review. Int J Chron Obstruct Pulmon
Dis. 13:409–418. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Baldacci F, Lista S, Cavedo E, Bonuccelli
U and Hampel H: Diagnostic function of the neuroinflammatory
biomarker YKL-40 in Alzheimer's disease and other neurodegenerative
diseases. Expert Rev Proteomics. 14:285–299. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ringel MD, Hayre N, Saito J, Saunier B,
Schuppert F, Burch H, Bernet V, Burman KD, Kohn LD and Saji M:
Overexpression and overactivation of Akt in thyroid carcinoma.
Cancer Res. 61:6105–6111. 2001.PubMed/NCBI
|
|
36
|
Sen P, Mukherjee S, Ray D and Raha S:
Involvement of the Akt/PKB signaling pathway with disease
processes. Mol Cell Biochem. 253:241–246. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tran NL, McDonough WS, Savitch BA, Sawyer
TF, Winkles JA and Berens ME: The tumor necrosis factor-like weak
inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14
(Fn14) signaling system regulates glioma cell survival via NFkappaB
pathway activation and BCL-XL/BCL-W expression. J Biol Chem.
280:3483–3492. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ameri H, Liu H, Liu R, Ha Y,
Paulucci-Holthauzen AA, Hu S, Motamedi M, Godley BF, Tilton RG and
Zhang W: TWEAK/Fn14 pathway is a novel mediator of retinal
neovascularization. Invest Ophthalmol Vis Sci. 55:801–813. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Whitsett TG, Cheng E, Inge L, Asrani K,
Jameson NM, Hostetter G, Weiss GJ, Kingsley CB, Loftus JC, Bremner
R, et al: Elevated expression of Fn14 in non-small cell lung cancer
correlates with activated EGFR and promotes tumor cell migration
and invasion. Am J Pathol. 181:111–120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kalhori V and Törnquist K: MMP2 and MMP9
participate in S1P-induced invasion of follicular ML-1 thyroid
cancer cells. Mol Cell Endocrinol. 404:113–122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Maeta H, Ohgi S and Terada T: Protein
expression of matrix metalloproteinases 2 and 9 and tissue
inhibitors of metalloproteinase 1 and 2 in papillary thyroid
carcinomas. Virchows Arch. 438:121–128. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Trimboli P, Virili C, Romanelli F,
Crescenzi A and Giovanella L: Galectin-3 performance in histologic
a cytologic assessment of thyroid nodules: A systematic review and
meta-analysis. Int J Mol Sci. 18:E17562017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cho SW, Kim YA, Sun HJ, Kim YA, Oh BC, Yi
KH, Park DJ and Park YJ: CXCL16 signaling mediated macrophage
effects on tumor invasion of papillary thyroid carcinoma. Endocr
Relat Cancer. 23:113–124. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xia S, Wang C, Postma EL, Yang Y, Ni X and
Zhan W: Fibronectin 1 promotes migration and invasion of papillary
thyroid cancer and predicts papillary thyroid cancer lymph node
metastasis. Onco Targets Ther. 10:1743–1755. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Semenza GL: The hypoxic tumor
microenvironment: A driving force for breast cancer progression.
Biochim Biophys Acta. 1863:382–391. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yu X, Zhao R, Lin S, Bai X, Zhang L, Yuan
S and Sun L: CXCL16 induces angiogenesis in autocrine signaling
pathway involving hypoxia-inducible factor 1α in human umbilical
vein endothelial cells. Oncol Rep. 35:1557–1565. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zheng J, Lu W, Wang C, Xing Y, Chen X and
Ai Z: Galectin-3 induced by hypoxia promotes cell migration in
thyroid cancer cells. Oncotarget. 8:101475–101488. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cui H, Grosso S, Schelter F, Mari B and
Krüger A: On the pro-metastatic stress response to cancer
therapies: Evidence for a positive co-operation between TIMP-1,
HIF-1α, and miR-210. Front Pharmacol. 3:1342012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Burrows N, Resch J, Cowen RL, von
Wasielewski R, Hoang-Vu C, West CM, Williams KJ and Brabant G:
Expression of hypoxia-inducible factor 1 alpha in thyroid
carcinomas. Endocr Relat Cancer. 17:61–72. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mahkamova K, Latar N, Aspinall S and
Meeson A: Hypoxia increases thyroid cancer stem cell-enriched side
population. World J Surg. 42:350–357. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hoenig MR, Bianchi C, Rosenzweig A and
Sellke FW: Decreased vascular repair and neovascularization with
aging: Mechanisms and clinical relevance with an emphasis on
hypoxia-inducible factor-1. Curr Mol Med. 8:754–767. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Valli A, Harris AL and Kessler BM: Hypoxia
metabolism in aging. Aging (Albany NY). 7:465–466. 2015. View Article : Google Scholar : PubMed/NCBI
|
